Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tandem Diabetes Care (TNDM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,091,137
  • Shares Outstanding, K 57,370
  • Annual Sales, $ -126,300 K
  • Annual Income, $ 115,230 K
  • 36-Month Beta 0.52
  • Price/Sales 18.76
  • Price/Cash Flow N/A
  • Price/Book 17.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.21
  • Number of Estimates 6
  • High Estimate -0.17
  • Low Estimate -0.24
  • Prior Year -1.23
  • Growth Rate Est. (year over year) +82.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.40 +40.68%
on 11/20/18
39.17 -5.18%
on 12/03/18
+4.43 (+13.54%)
since 11/12/18
3-Month
26.40 +40.68%
on 11/20/18
52.55 -29.32%
on 09/13/18
-11.48 (-23.61%)
since 09/12/18
52-Week
2.14 +1,635.51%
on 02/09/18
52.55 -29.32%
on 09/13/18
+34.63 (+1,379.68%)
since 12/12/17

Most Recent Stories

More News
Tandem Diabetes has the Best Relative Performance in the Health Care Equipment Industry (TNDM, EW , IDXX , MASI , RMD )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

EW : 163.14 (-0.03%)
TNDM : 37.14 (+1.89%)
IDXX : 199.73 (+1.66%)
Implied Volatility Surging for Tandem Diabetes (TNDM) Stock Options

Investors need to pay close attention to Tandem Diabetes (TNDM) stock based on the movements in the options market lately.

TNDM : 37.14 (+1.89%)
Dexcom has the Best Relative Performance in the Health Care Equipment Industry (DXCM , NVRO , TNDM, ISRG , ABMD )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

NVRO : 41.67 (+1.51%)
TNDM : 37.14 (+1.89%)
DXCM : 124.52 (+1.21%)
Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Virtu Financial, Inc. (NASDAQ:VIRT),...

TNDM : 37.14 (+1.89%)
GFF : 10.46 (-0.57%)
LLY : 114.34 (-0.14%)
CHRS : 10.02 (+1.42%)
FATE : 16.78 (+2.63%)
VIRT : 25.80 (+0.78%)
Why Is Tandem Diabetes (TNDM) Down 9.4% Since Last Earnings Report?

Tandem Diabetes (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TNDM : 37.14 (+1.89%)
Shares of Dexcom Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (DXCM , TNDM, GKOS , INGN , RMD )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

TNDM : 37.14 (+1.89%)
GKOS : 65.79 (-0.75%)
DXCM : 124.52 (+1.21%)
Tandem Diabetes has the Best Relative Performance in the Health Care Equipment Industry (TNDM, ABMD , GKOS , ISRG , MASI )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

TNDM : 37.14 (+1.89%)
ABMD : 330.69 (+0.78%)
GKOS : 65.79 (-0.75%)
Watch for Tandem Diabetes to Potentially Pullback After Gaining 2.57% Yesterday

Tandem Diabetes (NASDAQ:TNDM) traded in a range yesterday that spanned from a low of $31.60 to a high of $33.79. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of...

TNDM : 37.14 (+1.89%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Tandem Diabetes (TNDM, IVC , PODD , GKOS , NVRO )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

TNDM : 37.14 (+1.89%)
IVC : 5.22 (+5.24%)
PODD : 83.37 (+1.07%)
DexCom Amends Deal With Verily to Launch Advanced CGM by 2020

DexCom (DXCM) and Verily to collaborate on the development of additional products and software based on DexCom's profile in the future.

GOOGL : 1,073.73 (+1.14%)
TNDM : 37.14 (+1.89%)
BDX : 235.56 (-0.46%)
DXCM : 124.52 (+1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade TNDM with:

Business Summary

Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.

See More

Key Turning Points

2nd Resistance Point 39.33
1st Resistance Point 38.24
Last Price 37.14
1st Support Level 36.38
2nd Support Level 35.61

See More

52-Week High 52.55
Last Price 37.14
Fibonacci 61.8% 33.29
Fibonacci 50% 27.34
Fibonacci 38.2% 21.40
52-Week Low 2.14

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar